L04AC Interleukin inhibitors

Place in the ATC system

1. L Antineoplastic and immunomodulating agents 1,069 drugs
   1. L04 Immunosuppressants 246 drugs
      1. L04A Immunosuppressants 246 drugs
         1. L04AC Interleukin inhibitors 26 drugs
            1. L04AC01 Daclizumab 3 drugs
            2. L04AC02 Basiliximab 1 drug
            3. L04AC03 Anakinra 1 drug
            4. L04AC05 Ustekinumab 4 drugs
            5. L04AC07 Tocilizumab 3 drugs
            6. L04AC08 Canakinumab 2 drugs
            7. L04AC11 Siltuximab 1 drug
            8. L04AC12 Brodalumab 1 drug
            9. L04AC13 Ixekizumab 1 drug
            10. L04AC14 Sarilumab 2 drugs
            11. L04AC16 Guselkumab 1 drug
            12. L04AC17 Tildrakizumab 1 drug
            13. L04AC19 Satralizumab 1 drug
            14. L04AC21 Bimekizumab 1 drug
            15. L04AC22 Spesolimab 1 drug
            16. L04AC24 Mirikizumab 2 drugs

Active ingredients of the class

• Anakinra 1 drug
• Basiliximab 1 drug
• Bimekizumab 1 drug
• Brodalumab 1 drug
• Canakinumab 2 drugs
• Daclizumab 1 drug
• Daclizumab beta 2 drugs
• Guselkumab 1 drug
• Ixekizumab 1 drug
• Mirikizumab 2 drugs
• Sarilumab 2 drugs
• Satralizumab 1 drug
• Siltuximab 1 drug
• Spesolimab 1 drug
• Tildrakizumab 1 drug
• Tocilizumab 3 drugs
• Ustekinumab 4 drugs

Drugs in the class and its subclasses

Other classes of the same level

• L04AA Selective immunosuppressants 48 drugs
• L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors 20 drugs
• L04AD Calcineurin inhibitors 13 drugs
• L04AX Other immunosuppressants 47 drugs

Other names of the drug class

• English (United Kingdom): L04AC Interleukin inhibitors
• French: L04AC inhibiteurs d'interleukines
• German: L04AC Interleukin-Inhibitoren
• German (Austria): L04AC Interleukin-Inhibitoren
• Italian: L04AC Inibitori dell'interleuchine (privilegiare l'uso del Biosimilare - Riferimento DGR Puglia n.1188/2019. Trai farmaci Biologici prediligere, comunque, il farmaco con un costo teraia più favorevole. )
• Turkish: L04AC interlökin inhibitörleri
• Portuguese (Brazil): L04AC Inibidores interleukina
• German (Switzerland): L04AC Interleukin-Inhibitoren
• French (Switzerland): L04AC Inhibiteurs d'interleukines
• Italian (Switzerland): L04AC Inibitori dell'interleuchine (privilegiare l'uso del Biosimilare - Riferimento DGR Puglia n.1188/2019. Trai farmaci Biologici prediligere, comunque, il farmaco con un costo teraia più favorevole. )